drugset / Trial / NCT01224795

A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.

NCT01224795

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a study to evaluate the efficacy and safety of a single dose of intravenous peramivir versus placebo in adolescents and adults with acute uncomplicated influenza.

Timeline

Start
2010-10
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject PERAMIVIR ANHYDROUS Small molecule 10 mg/kg Intravenous
Subject PERAMIVIR ANHYDROUS Small molecule 600 mg Intravenous

Indications